Overview of Original Subscription Model and Features of LA and WA Proposals
An overview of the original subscription-based Netflix model proposed and the proposals put forth by Louisiana and Washington.
Originally published on 01/29/2019
The Drug Pricing Lab has proposed a subscription-based payment model that offers an unlimited amount of medications over a predetermined period of time specified in a multi-year contract with a state coalition of payers paying a flat annual subscription fee.
On January 10, 2019, officials in the state of Louisiana announced plans to proceed with a subscription-based payment model for providing hepatitis C treatment and have published a solicitation for offers to manufacturers to enter into negotiations. Additionally, Washington state released a request for proposals for a “modified subscription model” for treating HCV on January 22.
Here we present an overview of the original subscription-based Netflix model proposed and the proposals put forth by Louisiana and Washington.